Vote Scores

Home / Companies / Enanta Pharmaceuticals, Inc. / 11 Mar 2026

Meeting · year to 30 June 2026225 filers reporting

Enanta Pharmaceuticals, Inc.: meeting of 11 Mar 2026

Votes reported on Form N-PX, item by item

225 Form N-PX filers reported votes at the Enanta Pharmaceuticals, Inc. meeting of 11 Mar 2026. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

2 nominees; 90.2% of reported votes for; 21 filers withheld from or voted against at least one nominee.

316 vote records from 81 filers. 2 of the 81 filers that marked the item either way voted against management.

75.3% for0.0% against24.7% other2.5% against management81 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

343 vote records from 225 filers. 16 of the 220 filers that marked the item either way voted against management. 5 filers reported this item without a management mark.

90.2% for7.1% against2.7% other7.3% against management225 filers97.4% for2.6% against0.0% other2.6% against management23,051,010 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

158 vote records from 81 filers. 0 of the 81 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management81 filers100.0% for0.0% against0.0% against management5,944,389 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

158 vote records from 81 filers. 53 of the 81 filers that marked the item either way voted against management.

33.3% for66.7% against65.4% against management81 filers70.1% for29.9% against29.8% against management5,944,389 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalForForFor
State Street and SPDRForForFor
American CenturyForForFor
Franklin TempletonForForFor
InvescoSplit or no voteAgainst *For
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertSplit or no voteForFor
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesSplit or no voteForFor
SEISplit or no voteForFor
T. Rowe PriceSplit or no voteForFor
ThriventForForFor
Lincoln FinancialForForFor
VoyaForForFor
First TrustNo reportForNo report
Russell InvestmentsNo reportForNo report
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleNo reportForNo report
BNY MellonNo reportForNo report
PrincipalForForFor
Pacific Life fundsForForFor
Global XSplit or no voteForFor
Federated HermesNo reportForNo report
AllianceBernsteinNo reportForNo report
DWSForForFor
Janus HendersonNo reportForNo report
Neuberger BermanNo reportForNo report
BairdNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Enanta Pharmaceuticals, Inc. meeting?

225 Form N-PX filers reported votes at the meeting of 11 Mar 2026. On say-on-pay, 16 of 220 voted against management (7.3%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Enanta Pharmaceuticals, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Enanta Pharmaceuticals, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Enanta Pharmaceuticals, Inc. with a meeting date within three days of 11 Mar 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.